Covalent binding and interstrand cross-linking of duplex DNA by dirhodium(II,II) carboxylate compounds

Biochemistry

Volumn 44, Issue 3, 2005, Pages 996-1003

  Dunham, Shari U ^a   Chifotides, Helen T ^b   Mikulski, Szymon ^a   Burr, Amity E ^a   Dunbar, Kim R ^b  

^a Health Services and Department of Biology   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; COMPLEXATION; COORDINATION REACTIONS; CROSSLINKING; ELECTROPHORESIS; GELS; RHODIUM COMPOUNDS; SPECTROSCOPIC ANALYSIS;

BIOLOGICAL ACTIVITY; COVALENT BINDING; DENATURING POLYACRYLAMIDE GEL ELECTROPHORESIS (DPAGE); DIRHODIUM CARBOXYLATE COMPOUNDS; DUPLEX DNA;

DNA;

CARBOXYLIC ACID DERIVATIVE; DNA FRAGMENT; DOUBLE STRANDED DNA; RHODIUM DERIVATIVE; UREA;

ARTICLE; COVALENT BOND; CROSS LINKING; DNA ADDUCT; HEATING; MOLECULAR INTERACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SPECTROSCOPY; TEMPERATURE;

CARBOXYLIC ACIDS; DNA; DNA ADDUCTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; RHODIUM;

EID: 12344297694     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0486637     Document Type: Article

References (68)

1. Jamieson, E. R., and Lippard, S. J. (1999) Structure, recognition, and processing of cisplatin-DNA adducts, Chem. Rev. 99, 2467-2498.
2. Cohen, S. M., and Lippard, S. J. (2001) Cisplatin: from DNA damage to cancer chemotherapy, Prog. Nucleic Acid Res. Mol. Biol. 67, 93-130.
3. Reedijk, J. (2003) New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA, Proc. Natl. Acad. Sci. U.S.A. 100, 3611-3616.
4. Huang, J.-C., Zambie, D. B., Reardon, J. T., Lippard, S. J., and Sancar, A. (1994) HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease, Proc. Natl. Acad. Sci. U.S.A. 91, 10394-10398.
5. Zhai, X., Beckmann, H., Jantzen, H.-M., and Essigmann, J. M. (1998) Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription human upstream binding factor, Biochemistry 37, 16307-16315.
6. Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., and Lippard, S. J. (1999) Basis for recognition of cisplatin-modified DNA by high-mobility group proteins, Nature 399, 708-712.
7. Lee, K.-B., Wang, D., Lippard, S. J., and Sharp, P. A. (2002) Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase 11 in vitro, Proc. Natl. Acad. Sci. U.S.A. 99, 4239-4244.
8. Millard, J. T., Weidner, M. F., Kirchner, J. J., Ribeiro, S., and Hopkins, P. B. (1991) Sequence preferences of DNA interstrand crosslinking agents: quantitation of interstrand crosslink locations in DNA duplex fragments containing multiple crosslinkable sites, Nucleic Acids Res. 19, 1885-1891.
9. Brabec, V. (2002) DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair, Prog. Nucleic Acid Res. Mol. Biol. 71, 1-68.
10. Farrell, N. (2004) Polynuclear Platinum Drugs, in Metal Ions in Biological Systems (Sigel, A., and Sigel, H., Eds.) Vol. 42, pp 251-296, Marcel Dekker, New York.
11. Farrell, N., Qu, Y., Feng, L., and Van Houten, B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand crosslinking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with monomeric analogues, Biochemistry 29, 9522-9531.
12. Brabec, V., Kasparkova, J., Vrana, O., Cox, J. W., Qu, Y., and Farrell, N. (1999) DNA modifications by a novel bifuncional trinuclear platinum phase I anticancer agent, Biochemistry 38, 6781-6790.
13. Zhang, C. X., and Lippard, S. J. (2003) New metal complexes as potential therapeutics, Curr. Opin. Chem. Biol. 7, 481-489.
14. Chifotides, H. T., and Dunbar, K. R. (2005) Dirhodium Compounds, in Multiple Bonds Between Atoms (Cotton, F. A., Murillo, C. A., and Walton, R. A., Eds.) 3rd ed., Springer-Verlag, New York (in press).
15. Hughes, R. G., Bear, J. L., and Kimball, A. P. (1972) Synergistic effect of rhodium acetate and arabinosylcytosine on L1210, Proc. Am. Assoc. Cancer Res. 13, 120-120.
16. Howard, R. A., Kimball, A. P., and Bear, J. L. (1979) Mechanism of action of tetra-μ-carboxylatodirhodium(II) in L1210 tumor suspension culture, Cancer Res. 39, 2568-2573.
17. Erck, A., Rainen, L., Whileyman, J., Chang, I. M., Kimball, A. P., and Bear, J. L. (1974) Studies of rhodium(II) carboxylates as potential antitumor agents, Proc. Soc. Exp. Biol. Med. 145, 1278-1283.
18. Bear, J. L., Gray, H. B., Jr., Rainen, L., Chang, I. M., Howard, R., Serio, G., and Kimball, A. P. (1975) Interaction of rhodium(II) carboxylates with molecules of biologic importance, Cancer Chemother. Rep. 59, 611-620.
19. 2 on the replication of Ehrlich tumor cells in vivo, Korean Biochem. J. 9, 175-180.
20. Howard, R. A., Sherwood, E., Erck, A., Kimball, A. P., and Bear, J. L. (1977) Hydrophobicity of several rhodium(II) carboxylates correlated with their biologic activity, J. Med. Chem. 20, 943-946.
21. Zyngier, S., Kimura, E., and Najjar, R. (1989) Antitumor effects of rhodium(II) citrate in mice bearing Ehrlich tumors, Braz. J. Med. Biol. Res. 22, 397-401.
22. Reibscheid, E. M., Zyngier, S., Maria, D. A., Mistrone, R. J., Sinisterra, R. D., Couto, L. G., and Najjar, R. (1994) Antitumor effects of rhodium(II) complexes on mice bearing Ehrlich tumors, Braz. J. Med. Biol. Res. 27, 91-94.
23. Nothenberg, M. S., Zyngier, S. B., Giesbrecht, A. M., Gambardella, M. T. P., Santos, R. H. A., Kimura, E., and Najjar, R. (1994) Biological activity and crystallographic study of a rhodium propionate-metronidazole adduct, J. Braz. Chem. Soc. 5, 23-29.
24. Bear, J. L. (1986) Rhodium Compounds for Antitumor Use, in Precious Metals 1985: Proceedings of the Ninth International Precious Metals Institute Conference (Zysk, E. D., and Bonucci, J. A., Eds.) pp 337-344, International Precious Metals, Allentown, PA.
25. Clarke, M. J., and Stubbs, M. (1996) Interactions of Metallopharmaceuticals with DNA, in Metal Ions in Biological Systems (Sigel, A., and Sigel, H., Eds.) Vol. 32, pp 727-780, Marcel Dekker, New York.
26. Sorasaenee, K., Fu, P. K.-L., Angeles-Boza, A. M., Dunbar, K. R., and Turro, C. (2003) Inhibition of transcription in vitro by anticancer active dirhodium(II) complexes, Inorg. Chem. 42, 1267-1271.
27. Chifotides, H. T., Fu, P. K.-L., Dunbar, K. R., and Turro, C. (2004) Effect of equatorial ligands of dirhodium(II,II) complexes on the efficiency and mechanism of transcription inhibition in vitro, Inorg. Chem. 43, 1175-1183.
28. Rao, P. N., Smith, M. L., Pathak, S., Howard, R. A., and Bear, J. L. (1980) Rhodium(II) butyrate: A potential anticancer drug with cell cycle phase-specific effects in HeLa cells, J. Natl. Cancer Inst. 64, 905-911.
29. Howard, R. A., Spring, T. G., and Bear, J. L. (1976) The interaction of rhodium(II) carboxylates with enzymes, Cancer Res. 36, 4402-4405.
30. Chen, J., and Kostic, N. M. (1988) Binuclear transition-metal complexes as new reagents for selective cross-linking of proteins. Coordination of cytochrome c to dirhodium(II)-μ-tetraacetate, Inorg. Chem. 27, 2682-2687.
31. Trynda, L., and Pruchnik, F. (1995) Interactions of tetra-μ- acetatodirhodium(II) with human serum albumin, J. Inorg. Biochem. 58, 69-77.
32. Esposito, B. P., de Oliveira, E., Zyngier, S. B., and Najjar, R. (2000) Effects of serum albumin in some biological properties of rhodium(II) complexes, J. Braz. Chem. Soc. 11, 447-452.
33. Esposito, B. P., and Najjar, R. (2002) Interactions of antitumoral platinum group metallodrugs with albumin, Coord. Chem. Rev. 232, 137-149.
34. Tselepi-Kalouli, E., and Katsaros, N. (1990) The interaction of Rh(II) and Rh(III) with DNA, J. Inorg. Biochem. 40, 95-102.
35. de Souza Gil, E., Serrano, S. H. P., Ferreira, E. I., and Kubota, L. T. (2002) Electrochemical evaluation of rhodium dimer-DNA interactions, J. Pharm. Biomed. Anal. 29, 579-584.
36. Rainen, L., Howard, R. A., Kimball, A. P., and Bear, J. L. (1975) Complexes of rhodium(II) carboxylates with adenosine 5′-mono-, 5′-di-, and 5′-triphosphates, Inorg. Chem. 14, 2752-2754.
37. Pneumatikakis, G., and Hadjiliadis, N. (1979) Interactions of tetrakis-μ-acetato-dirhodium(II) with adenine nucleosides and nucleotides, J. Chem. Soc., Dalton Trans., 596-599.
38. Rubin, J. R., Haromy, T. P., and Sundaralingam, M. (1991) Structure of the anti-cancer drug complex tetrakis(μ-acetato)-bis-(1-methyladenosine) dirhodium(II) monohydrate, Acta Crystallogr. C47, 1712-1714.
39. Alberding, N., Farrell, N., and Crozier, E. D. (1985) Examination of rhodium carboxylate antitumor agents complexes with nucleosides by extended X-ray absorption fine structure spectroscopy, J. Am. Chem. Soc. 107, 384-388.
40. Farrell, N. (1980) Metal-purine complexes: factors affecting specific binding, J. Chem. Soc., Chem. Commun., 1014-1016.
41. Farrell, N. (1981) Adenine and adenosine derivatives of rhodium acetate, J. Inorg. Biochem. 14, 261-265.
42. Rubin, J. R., and Sundaralingam, M. (1984) Crosslinking of tRNAs by the carcinostatic agent dirhodium tetraacetate, J. Biomol. Struct. Dyn. 2, 525-530.
43. Dunbar, K. R., Matonic, J. H., Saharan, V. P., Crawford, C. A., and Christou, G. (1994) Structural evidence for a new metal-binding mode for guanine bases: implications for the binding of dinuclear antitumor agents to DNA, J. Am. Chem. Soc. 116, 2201-2202.
44. Crawford, C. A., Day, E. F., Saharan, V. P., Folting, K., Huffman, J. C., Dunbar, K. R., and Christou, G. (1996) N7,O6 bridging 9-ethylguanine (9-EtGH) groups in dinuclear metal-metal bonded complexes with bond orders of one, two or four, Chem. Commun., 1113-1114.
45. Chifotides, H. T., Koshlap, K. M., Pérez, L. M., and Dunbar, K. R. (2003) Unprecendented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis(μ-carboxylato)-dirhodium(II,II), J. Am. Chem. Soc. 125, 10703-10713.
46. Chifotides, H. T., Koshlap, K. M., Pérez, L. M., and Dunbar, K. R. (2003) Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(μ-carboxylato)dirhodium(II,II), J. Am. Chem. Soc. 125, 10714-10724.
47. Asara, J. M., Hess, J. S., Lozada, E., Dunbar, K. R., and Allison, J. (2000) Evidence for binding of dirhodium bis-acetate units to adjacent GG and AA sites on single-stranded DNA, J. Am. Chem. Soc. 122, 8-13.
48. Chifotides, H. T., Koomen, J. M., Kang, M., Dunbar, K. R., Tichy, S., and Russell, D. (2004) Binding of DNA purine sites to dirhodium compounds probed by mass spectrometry, Inorg. Chem. 43, 6177-6187.
49. Rempel, G. A., Legzdins, P., Smith, H., and Wilkinson, G. (1972) Tetrakis(acetato)dirhodium(II) and similar carboxylato compounds, Inorg. Synth. 13, 90-91.
50. 2, J. Chem. Soc., Dalton Trans., 1257-1263.
51. Cotton, F. A., and Felthouse, T. R. (1980) Ambidentate character of dimethyl sulfoxide in adducts of tetrakis(propionato)- and tetrakis(trifluoroacetato)dirhodium(II), Inorg. Chem. 19, 2347-2351.
52. 4 species, Inorg. Chem. 23, 1798-1803.
53. Gallagher, S. R. (1994) Quantitation of DNA and RNA with absorption and fluorescence spectroscopy, in Current Protocols in Molecular Biology (Chanda, V. B., Ed.) John Wiley & Sons, New York.
54. Hartley, J. L., and Oregon, T. J. (1981) Cloning multiple copies of a DNA segment, Gene 13, 347-353.
55. Kane, S. A., and Lippard, S. J. (1996) Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins, Biochemistry 35, 2180-2188.
56. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) in Molecular Cloning: A Laboratory Manual (Ford, N., Nolan, C., and Ferguson, M., Eds.) 2nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY.
57. Luce, R. A., and Hopkins, P. B. (2001) Chemical cross-linking of drugs to DNA, Methods Enzymol. 340, 396-412.
58. Brabec, V., and Leng, M. (1993) DNA Interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues, Proc. Natl. Acad. Sci. U.S.A. 90, 5345-5349.
59. Erck, A., Sherwood, E., Bear, J. L., and Kimball, A. P. (1976) The metabolism of rhodium(II) acetate in tumor-bearing mice, Cancer Res. 36, 2204-2209.
60. Chifotides, H. T., Hess, J. S., Angeles-Boza, A. M., Galán- Mascarós, J. R., Sorasaenee, K., and Dunbar, K. R. (2003) Structural evidence for monodentate binding of guanine to the dirhodium(II,II) core in a manner akin to that of cisplatin, Dalton Trans., 4426-4430.
61. 4(bpy), J. Am. Chem. Soc. 113, 2770-2771.
62. Lide, D. R. (2000-2001) CRC Handbook of Chemistry and Physics, 81st ed., CRC Press, New York.
63. Hopkins, P. B., Millard, J. T., Woo, J., Weidner, M. F., Kirchner, J. J., Sigurdsson, S. T., and Raucher, S. (1991) Sequence preferences of DNA interstrand cross-linking agents: importance of minimal DNA structural reorganization in the cross-linking reactions of mechlorethamine, cisplatin and mitomycin C, Tetrahedron 47, 2475-2489.
64. Shafranskii, V. N., and. Mal'kova, T. A. (1975) Compounds of dirhodium(II) diaquatetraacetate with urea and its derivatives, J. Gen. Chem. USSR 45, 1051-1054.
65. 4+, Inorg. Chim. Acta 206, 135-140.
66. 15N NMR and IR spectroscopic studies of a Rh(II) complex of thiourea, J. Coord. Chem. 56, 1587-1595.
67. Sorasaenee, K., Galán-Mascarós, J. R., and Dunbar, K. R. (2002) Reactivity studies of anticancer active dirhodium complexes with 2-aminothiophenol, Inorg. Chem. 41, 433-436.
68. 2, Inorg. Chem. 42, 661-663.